[HTML][HTML] Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor
J Kim, JH Kim, JY Lee, J Chun, JP Im, JS Kim - BMC gastroenterology, 2018 - Springer
Background The incidence of rectal neuroendocrine tumors (NETs) is rapidly increasing
because of the frequent use of endoscopic screening for colorectal cancers. However, the …
because of the frequent use of endoscopic screening for colorectal cancers. However, the …
[HTML][HTML] Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
I Abubakar, A Lalvani, J Southern, A Sitch… - Health technology …, 2018 - ncbi.nlm.nih.gov
BACKGROUND Despite a recent decline in the annual incidence of tuberculosis (TB) in the
UK, rates remain higher than in most Western European countries. The detection and …
UK, rates remain higher than in most Western European countries. The detection and …
Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population‐Based Cohort Study
MK de Vries, EV Arkema, J Jonsson… - Arthritis Care & …, 2018 - Wiley Online Library
Objective Rheumatoid arthritis is a risk factor for tuberculosis (TB), particularly following
treatment with biologic agents. Since these therapies are increasingly used in ankylosing …
treatment with biologic agents. Since these therapies are increasingly used in ankylosing …
Mycobacterium abscessus Infection During Ustekinumab Treatment in Crohn's Disease: A Case Report and Review of the Literature
HH Shim, SCS Cai, W Chan, JGH Low… - Journal of Crohn's …, 2018 - academic.oup.com
The introduction of ustekinumab, an interleukin [IL] 12/23 p40 inhibitor, to the therapeutic
armamentarium of Crohn's disease has provided a much needed treatment option for …
armamentarium of Crohn's disease has provided a much needed treatment option for …
[HTML][HTML] Incidence of active tuberculosis within one year after tumor necrosis factor inhibitor treatment according to latent tuberculosis infection status in patients with …
Background We investigated the incidence of active tuberculosis among patients with
inflammatory bowel disease (IBD) treated with tumor necrosis factor (TNF) inhibitors, with or …
inflammatory bowel disease (IBD) treated with tumor necrosis factor (TNF) inhibitors, with or …
[PDF][PDF] Федеральное государственное бюджетное образовательное учреждение высшего образования «Ульяновский государственный университет» …
ОВ Ершова - 2018 - abiturient.tusur.ru
Настоящее пособие предназначено, в первую очередь, для желающих поступить в
ТУСУР и для преподавателей осуществляющих их подготовку. Поскольку …
ТУСУР и для преподавателей осуществляющих их подготовку. Поскольку …
[PDF][PDF] Mycobacterium abscessus Infection During Ustekinumab Treatment in Crohn's Disease: A Case Report and Review of the Literature
HH Shima, SCS Caib, W Chana, JGH Lowc… - Journal of Crohn's and …, 2018 - academia.edu
The introduction of ustekinumab, an interleukin [IL] 12/23 p40 inhibitor, to the therapeutic
armamentarium of Crohn's disease has provided a much needed treatment option for …
armamentarium of Crohn's disease has provided a much needed treatment option for …
Incidência de tuberculose no Estado do Rio Grande do Sul em pacientes do Sistema Único de Saúde com doenças reumatológicas em uso de anti-fator de necrose …
NS Sartori - 2018 - lume.ufrgs.br
Introdução: A tuberculose (TB) é uma doença infecciosa, ocasionada pelo Mycobacterium
tuberculosis, com incidência elevada na população em geral no Brasil. O advento da …
tuberculosis, com incidência elevada na população em geral no Brasil. O advento da …
[PDF][PDF] Two interferon gamma release assays for predicting active tuberculosis
Ibrahim Abubakar, 1* Ajit Lalvani, 2 Jo Southern, 3 Alice Sitch, 4 Charlotte Jackson, 1
Oluchukwu Onyimadu, 5 Marc Lipman, 6 Jonathan J Deeks, 4 Chris Griffiths, 7 Graham …
Oluchukwu Onyimadu, 5 Marc Lipman, 6 Jonathan J Deeks, 4 Chris Griffiths, 7 Graham …